Exagen Inc.
A medical diagnostics company, Exagen makes blood tests that help rheumatologists tell apart autoimmune conditions like lupus and rheumatoid arthritis. Its flagship product, AVISE CTD, is processed in a single lab in Vista, California, with results typically ready in about five business days. Founded in 2002, the company grows its line of AVISE-branded tests, and the "CTD" in its flagship test's name stands for connective tissue disease—the family of illnesses it helps doctors sort out.
Sold 550.0K
Granted 468.3K · Bought 40.4K · Sold 92.7K
Granted 316.5K · Bought 22.3K · Sold 22.1K
Granted 75.0K · Sold 19.5K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Sun Mountain Capital Partners LLC +1 co-filer10% owner · 2 transactions | -23.8% | 1.76Mas of Mar 2025 | — | — | 550.0K |
| Aballi JohnPresident and CEO, Director · 12 transactions | — | 880.2K | 468.3K | 40.4K | 92.7K |
| Black Jeffrey G.Chief Financial Officer · 7 transactions | — | 342.4K | 316.5K | 22.3K | 22.1K |
| Adawi KamalCFO and Corporate Secretary · 4 transactions | +31.3% | 247.2Kas of Mar 2024 | 75.0K | — | 19.5K |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 3 years: -621.6K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.